Clinical trials
Phase 1 Temporomandibular Joint Disorders trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2007 | 1 |
| 2009 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2023 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Unknown status | 6 |
| Recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Abdelrahman Soliman Alateyh | 1 |
| Cairo University | 1 |
| Faculdade de Medicina de Petrópolis Faculdade Arthur Sá Earp Neto | 1 |
| Federal University of Uberlandia | 1 |
| Logan College of Chiropractic | 1 |
| Medical University of Silesia | 1 |
| National Center for Complementary and Integrative Health (NCCIH) | 1 |
| Shahid Beheshti University | 1 |
| Universidade Federal do Rio de Janeiro | 1 |
| University Medicine Greifswald | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Temporomandibular Joint Disorders | 14 |
| Chronic Pain | 2 |
| Temporomandibular Joint Dysfunction Syndrome | 2 |
| Bruxism | 1 |
| Chronic Disease | 1 |
| Craniomandibular Disorders | 1 |
| Joint Diseases | 1 |
| Joint Dislocations | 1 |
| Myofascial Pain Syndromes | 1 |
| Osteoarthritis | 1 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.